XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Cash equivalents $ 359,500,000   $ 266,000,000
Debt securities, available-for-sale 72,900,000 $ 210,600,000 210,600,000
Transfers between Level 1 and Level 2 securities 0   0
Transfers into or out of Level 3 securities 0   0
Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Cash equivalents 309,900,000   199,300,000
Debt securities, available-for-sale 0   0
Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Cash equivalents 49,600,000   66,700,000
Debt securities, available-for-sale 72,900,000   210,600,000
Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Cash equivalents 0   0
Debt securities, available-for-sale 0   0
U.S. government agencies      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 54,800,000 173,100,000 173,100,000
U.S. government agencies | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
U.S. government agencies | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 54,800,000   173,100,000
U.S. government agencies | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Corporate debt      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 15,100,000 1,300,000 1,300,000
Corporate debt | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Corporate debt | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 15,100,000   1,300,000
Corporate debt | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Commercial paper      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 3,000,000 36,200,000 36,200,000
Commercial paper | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Commercial paper | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 3,000,000   36,200,000
Commercial paper | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Equity investment in Tandem Diabetes Care, Inc      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Equity investment in Tandem Diabetes Care, Inc.     38,000,000
Equity investment in Tandem Diabetes Care, Inc | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Equity investment in Tandem Diabetes Care, Inc.     38,000,000
Equity investment in Tandem Diabetes Care, Inc | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Equity investment in Tandem Diabetes Care, Inc.     0
Equity investment in Tandem Diabetes Care, Inc | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Equity investment in Tandem Diabetes Care, Inc.     0
Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Fair value of outstanding senior convertible notes: 1,413,800,000 1,399,800,000  
Senior convertible notes due 2023 | Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Fair value of outstanding senior convertible notes: 876,300,000 859,600,000  
Senior convertible notes due 2022 | Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Fair value of outstanding senior convertible notes: 537,500,000 $ 540,200,000  
Foreign Exchange Forward | Designated as Hedging Instrument      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Outstanding currency hedging transactions 0    
Fair Value, Measurements, Recurring      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Total assets measured at fair value on a recurring basis 432,400,000   514,600,000
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Total assets measured at fair value on a recurring basis 309,900,000   237,300,000
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Total assets measured at fair value on a recurring basis 122,500,000   277,300,000
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Total assets measured at fair value on a recurring basis $ 0   $ 0